Does a high arachidonic acid to EPA ratio indicate more inflammatory signaling?

The balance between active inflammation and its resolution is fundamentally governed by the fatty acid composition of cellular membrane phospholipids, specifically the ratio of omega-6 arachidonic acid (AA) to omega-3 eicosapentaenoic acid (EPA).

Enzymatic competition and biochemical pathways

• Substrate competition: AA and EPA directly compete for metabolic conversion by cyclooxygenase (COX) and lipoxygenase (LOX) enzymes. Although AA is the kinetically preferred substrate for COX-1, exhibiting a higher enzyme affinity and turnover rate, EPA acts as a competitive inhibitor at these active sites when present in sufficient concentrations.
• Pro-inflammatory dominance: An elevated AA:EPA ratio minimizes the competitive inhibition exerted by EPA. This allows unhindered biochemical flux toward highly potent AA-derived pro-inflammatory eicosanoids, including prostaglandin E2 ($\text{PGE}_2$) and leukotriene B4 ($\text{LTB}_4$), which drive systemic and localized inflammatory cascades.
• Suppressed resolution: A high ratio simultaneously limits the synthesis of weaker, less inflammatory 3-series prostaglandins and 5-series leukotrienes. Furthermore, it depletes the substrate pool required to generate key specialized pro-resolving mediators (SPMs), such as E-series resolvins ($\text{RvE1}$), which are necessary to actively terminate the inflammatory response and promote tissue homeostasis.

Bottom line

• A high AA:EPA ratio serves as a precise biomarker reflecting a membrane-level and enzymatic bias toward sustained, pro-inflammatory eicosanoid signaling over anti-inflammatory and pro-resolving lipid mediator pathways.